1-23311326-T-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000302271.11(HNRNPR):c.1168-4A>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000641 in 1,548,914 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
ENST00000302271.11 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HNRNPR | NM_005826.5 | c.1168-4A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000302271.11 | NP_005817.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HNRNPR | ENST00000302271.11 | c.1168-4A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_005826.5 | ENSP00000304405 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000519 AC: 79AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000455 AC: 106AN: 233090Hom.: 1 AF XY: 0.000498 AC XY: 63AN XY: 126590
GnomAD4 exome AF: 0.000654 AC: 914AN: 1396694Hom.: 3 Cov.: 25 AF XY: 0.000631 AC XY: 440AN XY: 697582
GnomAD4 genome AF: 0.000519 AC: 79AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.000484 AC XY: 36AN XY: 74360
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at